The AI news for June 28-29, 2026, despite being the weekend, featured themes that symbolize the current state of the AI industry: a backlash against over-reliance on AI, alongside the simultaneous ...
🚑 Remix Therapeutics, a Watertown, Mass.-based RNA processing reprogramming biotech, is going public via a reverse merger with Passage Bio (Nasdaq: PASG). Remix has raised over $200m from firms like ...
This systems-level dysregulation is consistent with broad developmental reprogramming. Furthermore, experiences of discrimination in adulthood are associated with distinct gut microbiome profiles and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results